BackIN8bio Overview

IN8bio Net Tangible Assets

Track IN8bio's net tangible assets ($18M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$18.36M
↑ 20.50% YoYΔ $3.12M vs prior year quarter

Peer average / median

Loading

IN8bio Net Tangible Assets History

Loading

IN8bio vs. peers: Net Tangible Assets Comparison

Loading

IN8bio Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

IN8bio (INAB) FAQ

IN8bio (INAB) currently reports a net tangible assets of $18M as of June 2026. That compares with $15M in the prior-year period — up 20.5% year over year. Use the charts on this page to explore IN8bio's net tangible assets history and peer comparisons.

IN8bio's net tangible assets increased from $15M to $18M — a 20.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

IN8bio reported $18M in net tangible assets as of June 2026. That compares with $15M in the prior-year period — up 20.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $18M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for IN8bio, and consider following INAB for alerts when major investors trade the stock.

IN8bio is classified in the Healthcare sector. On net tangible assets, it currently shows $18M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INAB with unrelated industries.